Latest KFF Health News Stories
KFF Health News' 'What the Health?': On Capitol Hill, RFK Defends Firings at CDC
A combative Robert F. Kennedy Jr, the U.S. secretary of health and human services, appeared before a Senate committee Thursday, defending his firing of the newly confirmed director of the Centers for Disease Control and Prevention as well as other changes that could limit the availability of vaccines. Meanwhile, Congress has only a few weeks to complete work on annual spending bills to avoid a possible government shutdown and to ward off potentially large increases in premiums for Affordable Care Act health plans. Jessie Hellmann of CQ Roll Call, Sarah Karlin-Smith of Pink Sheet, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Tony Leys, who discusses his “Bill of the Month” report about a woman’s unfortunate interaction with a bat — and her even more unfortunate interaction with the bill for her rabies prevention treatment.
As Insurers Struggle With GLP-1 Drug Costs, Some Seek To Wean Patients Off
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.
Senior CDC Officials Resign After Monarez’s Ouster, Citing Concerns Over Scientific Independence
Four senior officials with the Centers for Disease Control and Prevention announced their resignations in recent days, citing what they described as growing political interference in the agency’s scientific work, particularly regarding vaccines.
FTC Has Long Said Products Must Back Up Health Claims. A MAHA Lawsuit Would Upend That.
Xlear, a maker of xylitol gum, has sued the Federal Trade Commission, saying the onus should be on government to prove that ingredients don’t live up to advertised claims. RFK Jr.’s “medical freedom” allies have rallied to the cause.
KFF Health News' 'What the Health?': Kennedy Cancels Vaccine Funding
The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses — and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but it’s unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Emmarie Huetteman to discuss these stories and more.
Chronically Ill? In Kennedy’s View, It Might Be Your Own Fault
In their zeal to “Make America Healthy Again,” top Trump administration officials depict patients and the doctors who treat them as partly responsible for whatever ails them.
KFF Health News' 'What the Health?': Here Come the ACA Premium Hikes
Medicaid may have monopolized Washington’s attention lately, but big changes are coming to the Affordable Care Act as well. Meanwhile, Americans are learning more about what’s in Trump’s big budget law, and polls suggest many don’t like what they see. Julie Appleby of KFF Health News, Jessie Hellmann of CQ Roll Call, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews historian Jonathan Oberlander to mark Medicare’s 60th anniversary.
KFF Health News' 'What the Health?': The Senate Saves PEPFAR Funding — For Now
The Senate narrowly approved the Trump administration’s request to claw back about $9 billion for foreign aid and public broadcasting but refused to cut funding for the international AIDS/HIV program PEPFAR. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other FDA-approved drugs. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.
Maybe It’s Not Just Aging. Maybe It’s Anemia.
Significant numbers of older people have the condition. Many find relief with an effective treatment that is being more widely prescribed.
Tal vez no es la edad, quizás tienes anemia
Los síntomas de la anemia —cansancio, dolor de cabeza, calambres en las piernas, frío, disminución de la capacidad para hacer ejercicio, confusión mental— a menudo se atribuyen al envejecimiento mismo.
Journalists Assess Health Impacts of Trump’s Megabill, Who Will Feel Them, and When
KFF Health News journalists made the rounds on national and regional media this week to discuss topical stories. Here’s a collection of their appearances.
KFF Health News' 'What the Health?': Supreme Court Upholds Bans on Gender-Affirming Care
The Supreme Court this week said Tennessee may continue to enforce its law banning most types of gender-affirming care for minors. The ruling is likely to greenlight similar laws in two dozen states. And the Senate is preparing to vote on a budget reconciliation bill that includes even deeper Medicaid cuts than the House version. Victoria Knight of Axios, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.
In Axing mRNA Contract, Trump Delivers Another Blow to US Biosecurity, Former Officials Say
The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health budgets, and withdraws funding for bird flu vaccines, health security experts said.
Two Patients Faced Chemo. The One Who Survived Demanded a Test To See if It Was Safe.
Worried that President Donald Trump’s FDA might not act, a panel of cancer experts recommended that doctors consider testing before dosing patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.
Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions
According to the timeline in the May 12 executive order, prescription drug price reductions would not happen “almost immediately,” but rather could take months or years. And extending the savings to Americans outside federal health insurance programs such as Medicare would likely require congressional action.
How Trump Aims To Slash Federal Support for Research, Public Health, and Medicaid
One thing experts agree on: The damage from the funding cuts will be varied and immense.
Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs
While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.
KFF Health News' 'What the Health?': GOP Tries To Cut Billions in Health Benefits
GOP-controlled House committees approved parts of President Donald Trump’s “one big, beautiful bill” this week, including more than $700 billion in cuts to health programs over the next decade — mostly from Medicaid, which covers people with low incomes or disabilities. Meanwhile, Health and Human Services Secretary Robert F. Kennedy Jr. testified before Congress for the first time since taking office and told lawmakers that Americans shouldn’t take medical advice from him. Julie Appleby of KFF Health News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more.
Pain Clinic CEO Faced 20 Years for Making Patients ‘Human Pin Cushions.’ He Got 18 Months.
Michael Kestner, CEO of Pain MD, was convicted of 13 fraud felonies after his company gave patients hundreds of thousands of questionable injections at clinics in Tennessee, Virginia, and North Carolina.
Honey, Sweetie, Dearie: The Perils of Elderspeak
A new training program teaches workers to stop the baby talk and address older people as adults.
